Abstract:ABSTRACT:Objective To study the efficacy and safety of oxcarbazepine (OXC)oral suspension on children with different kinds of epilepsy.Methods A total of 83 children with epilepsy were selected from the Pediatric Department of the First Affiliated Hospital of Xi’an Jiaotong University and Xi’an Children’Hospital from June 201 1 to June 2014.They were treated with OXC monotherapy or adjunctive therapy.Use open-label and self-contrast method.The initial dose of OXC was 8 -10 mg/(kg·d),and then was added 10 mg/(kg·d)per 7 days until it reached the minimum effective dose.Generally,the maintenance dose was about 20-40 mg/(kg·d).The follow-up duration was 6 - 12 months.Results 83 cases were eventually included and 5 cases withdrew.We elvaluated the efficacy every 3 months.The results were as follows:the first stage (1,2,3 months)resulted in a 41.0% of full control rate and a 71.8% of total effective rate;the second stage (4,5,6 months)resulted in a 46.2% of full control rate and a 76.9% of total effective rate;the third stage (7,8,9 months)resulted in a 59.0%of full control rate and a 79.5% of total effective rate.There were no significant differences in the efficacy of the three stages.54 cases with partial seizures resulted in a 59.3% of full control rate and a 79.6% of total effective <br> rate;24 cases with generalized seizure resulted in a 45.8% of full control rate and a 62.5% of total effective rate. There was no statistical significant difference in the efficacy of the two seizure types.43 cases with monotherapy resulted in a 58% of full control rate and a 79% of total effective rate,35 cases with add-on therapy resulted in a 40.0% of full control rate and a 57.1% of total effective rate.24 cases with < 2 resulted in a 41.7% of full control rate and a 62.5% of total effective rate,54 cases with 2-6 resulted in a 59.3% of full control rate and a 83.3% of total effective rate.14 cases of children were reported to have at least one adverse drug reactions,the specific symptoms included emotional instability unstable, hypohidrosis, somnolence, dizzness, headache, vomiting, urorrhea,lack of appetite,aggressive behavior and hypomnesia.Adverse reactions were mild and most of them could subside over time.Conclusion OXC oral suspension has a good efficacy and safety when treating children with partial seizures or generalized tonic-clonic seizures of epilepsy.

Efficacy, tolerability, and pharmacokinetics of oxcarbazepine oral loading in patients with epilepsy

Efficacy of Low to Moderate Doses of Oxcarbazepine in Adult Patients with Newly Diagnosed Partial Epilepsy

Reintroduction of Oxcarbazepine after Allergic Reaction in Two Pediatric Patients with Epilepsy

Efficacy and safety of oxcarbazepine oral suspension in epileptic children:a clinical study

Clinical observation of oxcarbazepine as an add-on therapy in patients with adults refractory partial-onset epilepsy

Oxcarbazepine Oral Suspension in Partial Epilepsy of Preschool-Aged Children: an Efficacy and Safety Study

Prospective Research on the Efficacy and Safety of Oxcarbazepine As Monotherapy and Add-on Therapy for Partial Epilepsy

Population pharmacokinetic model development and its relationship with adverse events of oxcarbazepine in adult patients with epilepsy

Clinical Observation of Oxcarbazepine on the Children with Epilepsy

Safety and efficacy of rapid withdrawal of antiseizure medications during long-term video-electroencephalogram monitoring in children with drug-resistant epilepsy: A retrospective study

Population pharmacokinetics of oxcarbazepine and its monohydroxy derivative in epileptic children

Oxcarbazepine oral suspension in pediatric patients with partial seizures and/or generalized tonic-clonic seizures: a multi-center, single arm, observational study in China

Population pharmacokinetics and dose simulation of oxcarbazepine in Chinese paediatric patients with epilepsy

Efficacy and tolerability of oxcarbazepine in the treatment of focal epilepsy in neonates and infants under 3 months of age: A single-center retrospective analysis

Population Pharmacokinetics Modeling of Oxcarbazepine to Characterize Drug Interactions in Chinese Children with Epilepsy

Population pharmacokinetics of oxcarbazepine: a systematic review

Chronic Treatment with Oxcarbazepine Attenuates Its Anticonvulsant Effect in the Maximal Electroshock Model in Mice

Population pharmacokinetics of oxcarbazepine 10-monohydroxy derivative in Chinese adult epileptic patients

Oxcarbazepine Versus Carbamazepine in the Treatment of Paroxysmal Kinesigenic Dyskinesia

Population Pharmacokinetic Modeling of Oxcarbazepine Active Metabolite in Chinese Patients with Epilepsy.

Bone Metabolism in Epileptic Patients with Oxcarbazepine Monotherapy: A Systematic Review